Medicare AdvantageCoverageMedium impact
MA08.012d, Off-label Coverage for Prescription Drugs and/or Biologics
Independence Blue Cross·Pharmacy
Effective date
Apr 1, 2026
We identified it
Jun 19, 2026
Summary
Medicare Advantage policy MA08.012d regarding off-label coverage for prescription drugs and biologics has been reissued with an effective date of April 1, 2026. This policy update affects pharmacy coverage rules for off-label use of medications and biologics under Medicare Advantage plans.
Action Required
By April 1, 2026: Review updated off-label drug and biologic coverage criteria for Medicare Advantage patients. Ensure prior authorization processes align with new policy requirements. Monitor for additional detailed policy guidance as the effective date approaches since only summary information is currently available.